Graphic: Vioxx Legal Resources.com
Offices

Image: Gavel and Law Books
Attorney Advertising Disclaimer


Graphic: Summary tab
Vioxx Recall: The international prescription drug company Merck announced in September 2004 the worldwide withdrawal of the arthritis medication Rofecoxib, sold in most countries under the brand name Vioxx, because a study showed an increased risk of heart attack and stroke.

Vioxx Trial: Patients who have suffered injuries due to Vioxx have filed litigation against Merck for selling Vioxx even though Merck allegedly was aware of Vioxx's dangerous side effects.


 


Lieff Cabraser Vioxx Injury
Attorneys - Our Offices

  
San Francisco
Embarcadero Center West
275 Battery Street, Suite 3000
San Francisco, CA 94111-3339
Tel. (415) 956-1000
Fax. (415) 956-1008

Map/Directions

    
  
New York
780 Third Avenue, 48th Floor
New York, NY 10017-2024
Tel. (212) 355-9500
Fax. (212) 355-9592

Map/Directions
    
Nashville
One Nashville Place
150 Fourth Ave. N., Ste. 1650
Nashville, TN 37219-2423
Tel. (615) 313-9000
Fax. (615) 313-9965

Map/Directions

Images: Supreme Court, Law Books, Scales and pill images
Lieff Cabraser Heimann & Bernstein, LLP

Trademark Notice
"Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

Copyright © 2007 Lieff Cabraser Heimann & Bernstein, LLP

Graphic: Latest News
Merck Agrees to Resolve U.S. VIOXX® Product Liability Lawsuits
November 9, 2007
 
Merck & Co., Inc. announced that it has entered into an agreement to resolve state and federal myocardial infarction (MI) and ischemic stroke claims already filed against the Company in the United States. More...


Graphic: Verdicts & Settlements header


Graphic: Press Articles


Graphic: Timeline